About eMed Technologies
eMed Technologies is a company based in Chicago (United States) founded in 1987. eMed Technologies has raised $200 million across 3 funding rounds from investors including Aon, Antonio Gracias and Joe Lonsdale. eMed Technologies has completed 1 acquisition, including Science 37. eMed Technologies offers products and services including Population Health Platform, Proctoring Service, and Predictive Analytics Tool. eMed Technologies operates in a competitive market with competitors including Healow, ALYKA Health, OnGo, Immuware and immuny, among others.
- Headquarter Chicago, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
$1.33 M (USD)-20as on Dec 31, 2023
-
Net Profit
$80.21 K (USD)32as on Dec 31, 2023
-
EBITDA
Not available
-
Total Equity Funding
$200 M (USD)
in 3 rounds
-
Latest Funding Round
$200 M (USD), Series A
Mar 26, 2026
-
Investors
Aon
& 3 more
-
Employee Count
Not available
- Investments & Acquisitions
-
Acquired by
N/A
(Oct 14, 2004)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of eMed Technologies
eMed Technologies offers a comprehensive portfolio of products and services, including Population Health Platform, Proctoring Service, and Predictive Analytics Tool.
AI-driven platform for GLP-1s/GIPs access and monitoring services
Mobile-based proctoring for drug prescribing and adherence checks
Tool for daily ROI analysis in health programs
People of eMed Technologies
Unlock access to complete
Unlock access to complete
Funding Insights of eMed Technologies
eMed Technologies has successfully raised a total of $200M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $200 million completed in March 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in eMed Technologies
eMed Technologies has secured backing from 3 investors, including institutional and angel investors. Prominent investors backing the company include Aon, Antonio Gracias and Joe Lonsdale.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Insurance brokerage and risk management services are provided worldwide.
|
Locked | Locked | Locked | |
|
AG
Antonio Gracias |
-
|
Locked | Locked | Locked |
|
JL
Joe Lonsdale |
-
|
Locked | Locked | Locked |
Investor details for eMed Technologies
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by eMed Technologies
eMed Technologies has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Science 37.
Investment portfolio details for eMed Technologies
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Provider of a suite solution for clinical trials for researchers
|
Locked | Locked | 2014 | Locked |
Complete acquisition details for eMed Technologies
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - eMed Technologies
Detailed financials for eMed Technologies
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Emed Technologies Comparisons
Peer comparison for eMed Technologies
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of eMed Technologies
eMed Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Healow, ALYKA Health, OnGo, Immuware and immuny, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provides a personal health record and appointment booking portal for users.
|
|
| Locked | Locked | Locked |
Digital app providing ongoing heart health monitoring and lifestyle advice for patients.
|
|
| Locked | Locked | Locked |
Provides rapid antigen tests and app for COVID-19 detection for individuals and businesses.
|
|
| Locked | Locked | Locked |
Employee health, immunizations, and safety incidents are tracked and reported.
|
|
| Locked | Locked | Locked |
Provides a platform for monitoring COVID-19 vaccination and test records for employees and individuals.
|
Detailed competitors of eMed Technologies
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Emed Technologies
Complete news archive for eMed Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about eMed Technologies
eMed Technologies was founded in 1987 and raised its 1st funding round 35 years after it was founded.
eMed Technologies is headquartered in Chicago, United States. It is registered at Chicago, Illinois, United States.
eMed Technologies is a funded company, having raised a total of $200M across 3 funding rounds to date.
Annual revenue of eMed Technologies is $1.33M as on Dec 31, 2023.
eMed Technologies was founded in 1987 and is headquartered in Chicago, United States. Software solutions for online test management are developed and offered, targeting employee evaluations and training needs. Operations center on the human resources technology sector, with services including customizable testing platforms accessible via the emed.com domain. Focus remains on efficient, web-based tools for organizational use across the country.
eMed Technologies's top competitors include Immuware, Healow and ALYKA Health.
eMed Technologies offers Population Health Platform, Proctoring Service, and Predictive Analytics Tool.
eMed Technologies has made 1 acquisition, including Science 37.
eMed Technologies has 3 investors. Key investors include Aon, Antonio Gracias, and Joe Lonsdale.